North Crest Asset Manangement, LLC Vir Biotechnology, Inc. Transaction History
North Crest Asset Manangement, LLC
- $3.19 Billion
- Q4 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 11,700 shares of VIR stock, worth $141,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,700
Previous 11,700
-0.0%
Holding current value
$141,570
Previous $87,000
2.3%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
216Shares Held
86.7MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$202 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$68.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$43.2 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.6B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...